Quote, Chart, News
Snapshot
Company Report
Quotes
Charts
Key Developments
Recent News
Research
SEC Filings
Advisor FYI
CAPS
StockScouter
Earnings Estimates
Analyst Ratings
Financial Results
- Highlights
- Key Ratios
- Statements
Insider Trading
Ownership
Message Board
Guided Research
Research Wizard
Find Stocks
Stock Screener
Stock Power Searches
Top-Rated Stocks
Related Links
Quote Watchlist
Expert Picks
E-mail & Alerts
IPO Center
Message Boards
Capital Gains Analysis

You can't view information about this ticker symbol because JavaScript is not enabled for your web browser. To enable JavaScript, consult online Help for your browser.

Alexion Pharmaceuticals Inc: Financial Statement

Business Type: Industry

Financial statements are prepared in this standard format to allow direct comparisons of all companies and industries across multiple time frames.

See 10K and 10Q SEC Filings for as reported statements

AnnualInterim

Financial data in U.S. Dollars
Values in Millions (Except for per share items)

2008

2007

2006

2005

Period End Date

12/31/2008

12/31/2007

12/31/2006

12/31/2005

07/31/2005

Period Length

12 Months

5 Months

12 Months

Stmt Source

10-K

10-KT

10-K

Stmt Source Date

02/23/2009

02/29/2008

02/23/2007

03/07/2006

10/11/2005

Stmt Update Type

Updated

Revenue

259.1

72.04

1.56

0.66

1.06

Total Revenue

259.1

72.04

1.56

0.66

1.06

Cost of Revenue, Total

28.37

6.7

0.0

Gross Profit

230.73

65.35

1.56

0.66

1.06

Selling/General/Administrative Expenses, Total

133.54

96.14

54.88

12.76

18.95

Research & Development

62.58

68.96

83.23

48.24

91.39

Depreciation/Amortization

0.0

Interest Expense (Income), Net Operating

0.0

Unusual Expense (Income)

0.0

0.54

0.0

-0.62

Other Operating Expenses, Total

0.0

Operating Income

34.61

-99.76

-137.09

-60.34

-108.66

Interest Income (Expense), Net Non-Operating

0.0

Gain (Loss) on Sale of Assets

0.0

Other, Net

0.0

Income Before Tax

34.73

-93.04

-131.89

-58.41

-109.52

Income Tax - Total

1.58

-0.75

-0.37

-0.45

-0.77

Income After Tax

33.15

-92.29

-131.51

-57.96

-108.75

Minority Interest

0.0

Equity In Affiliates

0.0

U.S. GAAP Adjustment

0.0

Net Income Before Extra. Items

33.15

-92.29

-131.51

-57.96

-108.75

Total Extraordinary Items

0.0

Net Income

33.15

-92.29

-131.51

-57.96

-108.75

Total Adjustments to Net Income

0.0

Basic Weighted Average Shares

77.68

72.62

63.4

61.05

55.7

Basic EPS Excluding Extraordinary Items

0.43

-1.27

-2.07

-0.95

-1.95

Basic EPS Including Extraordinary Items

0.43

-1.27

-2.07

-0.95

-1.95

Diluted Weighted Average Shares

89.97

72.62

63.4

61.05

55.7

Diluted EPS Excluding Extrordinary Items

0.39

-1.27

-2.07

-0.95

-1.95

Diluted EPS Including Extraordinary Items

0.39

-1.27

-2.07

-0.95

-1.95

Dividends per Share - Common Stock Primary Issue

0.0

Gross Dividends - Common Stock

0.0

Interest Expense, Supplemental

2.41

2.49

2.84

1.19

6.13

Depreciation, Supplemental

5.69

4.24

3.03

1.69

3.81

Normalized EBITDA

41.47

-95.25

-133.52

-58.36

-104.78

Normalized EBIT

34.61

-99.76

-136.55

-60.34

-109.28

Normalized Income Before Tax

34.73

-93.04

-131.35

-58.41

-110.13

Normalized Income After Taxes

33.15

-92.29

-131.16

-57.96

-109.15

Normalized Income Available to Common

33.15

-92.29

-131.16

-57.96

-109.15

Basic Normalized EPS

0.43

-1.27

-2.07

-0.95

-1.96

Diluted Normalized EPS

0.39

-1.27

-2.07

-0.95

-1.96

Amortization of Intangibles

1.18

0.26

0.0

0.28

0.69

Data providers
Quotes supplied by Interactive Data Real-Time Services.